All Personal view articles
View all stories of the same content type.
-
Personal view
Opportunities for early diagnosis of serious disease are being missed due to PPE shortages
GPs have resorted to community charity to acquire PPE and are risking their lives to see patients. This article reveals the extent of the problem in primary care and the adaptions that have been made.
-
Personal view
Personal view: is it time to change our UK prescribing strategy for asthma?
Dr Mark L Levy argues that current UK treatment regimens for asthma are not as safe or effective as the ones recommended in the updated GINA asthma strategy
-
Personal view
A personal critique of the NICE guideline on asthma
Dr Mark L Levy gives his personal view of the differences between recommendations from NICE and those presented in previous guidelines from BTS/SIGN and GINA
-
Personal view
Asthma: do different guideline strategies affect outcomes?
Dr Mark L Levy compares some of the recommendations from GINA and BTS/SIGN on asthma and considers how different approaches might impact on diagnosis, assessment, and patient mortality
-
Personal view
COPD: therapy should be tailored to the individual
Dr Chris Cooper reviews the 2017 GOLD COPD update and provides insight into the most significant changes to clinical practice
-
Personal view
QALY cost threshold: is it time for a rethink?
Dr Alistair Blair discusses proposed changes to arrangements for access to new drugs and medical technologies
-
Personal view
Asthma update: attention to detail is key
Dr Andy Whittamore explains why the updated BTS/SIGN asthma guideline is important for improving practice and patient outcomes
-
Personal view
Care of the skin barrier is crucial in atopic eczema
Dr George Moncrieff discusses possible causes of atopic eczema and offers his personal approach to managing this distressing condition
-
Personal view
Will the NICE type 2 diabetes guidance meet expectations?
Professor Roger Gadsby reviews proposed updates to the NICE guideline on type 2 diabetes in adults and the areas of concern
-
Personal view
Should everyone with a 10% risk of CVD take a statin?
Dr Terry McCormack revisits recent controversies about NICE guidance on statins and offers patient scenarios illustrating his own approach in clinical practice
-
Personal view
Managing IBD in general practice: sharing care
Drs Chris Alexakis, Sonia Saxena and Richard Pollok discuss management of inflammatory bowel disease
-
Personal view
Chronic hepatitis B can be successfully treated
Prof Howard Thomas highlights the importance of identification, treatment, and vaccination in an overview of chronic hepatitis B
-
Personal view
New guideline on AF will boost stroke prevention
Dr Dipankar Dutta discusses key updated NICE recommendations on stroke assessment and prevention in atrial fibrillation
-
Personal view
Type 2 diabetes guidance: what does the future hold?
Professor Roger Gadsby discusses the major issues impacting on the pending revised NICE type 2 diabetes guidelines
-
Personal view
Lifetime CVD risk calculator invites earlier interventions
Dr Alan Begg summarises key aspects of JBS3 that are relevant to primary care and considers some implications for clinical practice
-
Personal view
Early treatment for PAD can address risks and outcomes
Prompt diagnosis of peripheral arterial disease can optimisepain-free mobility and avoid future amputations, says Dr Alan Begg
-
Personal view
Fibromyalgia is a clinical diagnosis for primary care
Patients with fibromyalgia benefit from a positive, multimodal approach, say Dr Asim Suleman and Dr Adrian Dunbar
-
Personal view
Detailed assessment and safe therapies are needed for ED
Professor Geoffrey Hackett explains why ED is an important marker for men’s health and why prescribing options should be widened
-
Personal view
Cow's milk allergy in infants is still under-diagnosed
Dr Adrian Morris presents his personal approach to the different types of cow's milk sensitivity seen in young children.
-
Personal view
Prompt treatment is crucial in management of acute STEMI
Primary percutaneous coronary intervention for STEMI improves outcomes if it can be delivered in time, says Dr Alan Begg